The release of proteins from tumors triggers an immune response in cancer patients. These
tumor antigens arise from several mechanisms including tumor-specific alterations in protein …

Detecting and removing high-risk adenomas and early colorectal cancer (CRC) can reduce
mortality of this disease. The noninvasive fecal occult blood test (FOBT; guaiac-based or …

MicroRNAs (miRNA) are small RNA molecules of∼ 20 to 22 nucleotides that reduce
expression of proteins through mRNA degradation and/or translational silencing. Each …

The receptor for hyaluronan-mediated motility (RHAMM), an acidic coiled coil protein, has
previously been characterized as a cell surface receptor for hyaluronan, and a microtubule …

Embryonic and extra-embryonic lineages are separated at the blastocyst stage in the mouse
at the onset of implantation but well ahead of implantation in most mammals. To provide …

Purpose: Prostate tumors express antigens that are recognized by the immune system in a
significant proportion of patients; however, little is known about the effect of standard …

The functional complexity of higher organisms is not easily accounted for by the size of their
genomes. Rather, complexity appears to be generated by transcriptional, translational, and …

Abstract RIO Kinase 1 (RIOK1) is involved in various pathologies, including cancer.
However, the role of RIOK1 in radioresistance of colorectal cancer (CRC) remains largely …

The prognosis of glioma is poor as its pathogenesis and mechanisms underlying cisplatin
chemoresistance remain unclear. Nucleosome assembly protein 1 like 1 (NAP1L1) is …

Aggressive fibromatosis (desmoid tumor) is a locally invasive soft tissue neoplasm
associated with mutations resulting in β-catenin-mediated transcriptional activation. This …